Search by Drug Name or NDC

    NDC 55150-0155-20 Acyclovir Sodium 1000 mg/20mL Details

    Acyclovir Sodium 1000 mg/20mL

    Acyclovir Sodium is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is ACYCLOVIR SODIUM.

    Product Information

    NDC 55150-0155
    Product ID 55150-155_410e306b-e8b9-4ff5-b703-a3005eec272f
    Associated GPIs 12405010102030
    GCN Sequence Number 038954
    GCN Sequence Number Description acyclovir sodium VIAL 50 MG/ML INTRAVEN
    HIC3 W5A
    HIC3 Description ANTIVIRALS, GENERAL
    GCN 43396
    HICL Sequence Number 004182
    HICL Sequence Number Description ACYCLOVIR SODIUM
    Brand/Generic Generic
    Proprietary Name Acyclovir Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acyclovir Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 1000
    Active Ingredient Units mg/20mL
    Substance Name ACYCLOVIR SODIUM
    Labeler Name Eugia US LLC
    Pharmaceutical Class DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203701
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0155-20 (55150015520)

    NDC Package Code 55150-155-20
    Billing NDC 55150015520
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-155-20) / 20 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2013-10-11
    NDC Exclude Flag N
    Pricing Information N/A